| 曲 颖,山 磊,刘长喜,赵 克,肖汝南,沈晓婷.A型肉毒毒素联合肌电生物反馈治疗脑卒中后上肢肌痉挛的临床疗效分析[J].,2017,17(27):5323-5326 |
| A型肉毒毒素联合肌电生物反馈治疗脑卒中后上肢肌痉挛的临床疗效分析 |
| Analysis of the Clinical Effect of Botulinumtoxin Type A(Botox-A) Combined with Electromyographic Biofeedback Therapy on the Upper Limb Muscle Spasm after Stroke |
| 投稿时间：2017-03-11 修订日期：2017-04-09 |
| DOI：10.13241/j.cnki.pmb.2017.27.031 |
| 中文关键词: 脑卒中 上肢肌痉挛 A型肉毒毒素 肌电生物反馈 |
| 英文关键词: Stroke Upper limb muscular spasticity Botulinumtoxin type A Electromyographic biofeedback |
| 基金项目: |
|
| 摘要点击次数: 249 |
| 全文下载次数: 114 |
| 中文摘要: |
| 摘要 目的：分析A型肉毒毒素与肌电生物反馈联合用于治疗脑卒中后上肢肌痉挛的临床疗效。方法：选择2014年10月至2016年12月辽宁本溪市中心医院和北京博爱医院收治的84例脑卒中后上肢肌痉挛患者，并将其随机分为观察组和对照组，每组42例。两组患者均首先接受常规康复训练，随后对照组加用肌电生物反馈治疗，观察组患者在对照组的基础之上注射A型肉毒毒素。采用改良Ashworth痉挛量表(MAS)比较两组治疗前后的上肢肌痉挛改善情况，采用Fugl-Meyer评定量表评价患者上肢运动功能，采用量角器测量治疗前后患者的腕关节主动活动范围，采用改良的Barthel指数评价患者治疗前后的日常生活能力。结果：治疗后，观察组的上肢痉挛改善总有效率显著高于对照组(P<0.05)；治疗2周和4周时，两组的Fugl-Meyer评分、腕关节主动活动范围、改良的Barthel指数(MBI)均较治疗前显著升高(P<0.05)，且观察组治疗后2周和4周的Fugl-Meyer评分、腕关节主动活动范围、改良的Barthel指数(MBI)均显著高于对照组(P<0.05)。结论：A型肉毒毒素与肌电生物反馈联合用于治疗脑卒中后上肢肌痉挛的临床疗效显著，可有效降低患者上肢痉挛状态，改善上肢和腕部运动能力，提高患者的日常生活能力。 |
| 英文摘要: |
| ABSTRACT Objective: To investigate the clinical effect of botulinumtoxin type A(Botox-A) combined with electromyographic biofeedback therapy on the upper limb muscle spasm after stroke. Methods: 86 cases of patients with upper limb muscle spasm after stroke in our hospital from January 2016 to January 2017 were selected and divided into the observation group and the control group, with 43 cases in each group. Patients in the control group were treated with electromyographic biofeedback therapy, and the observation group was treated with Botox-A based on the basis of control group. The improvement of upper limb muscle spasm, Upper limb move- ment function, the active range of wrist joint and life skills before and after treatment were compared between two groups. Results: After treatment, the total effective rate of improvement of upper limb muscle spasm of observation group were significantly higher than that of the control group(P<0.05); At 2 weeks and 4 weeks after treatment, the Fugl-Meyer scores, Wrist joint activities, modified Barthel index (MBI) of two groups were significantly higher than those before treatment(P<0.05), which were significantly higher in the observation group than those of the control group(P<0.05). Conclusion: Botox-Acombined with electromyographic biofeedback therapy had remark- able clinical effect on the upper limb muscle spasm after stroke, which could effectively reduce the upper limb spasticity, improve the arm and wrist movement ability and the ability of daily life. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
